The role of anthracyclines in adult acute lymphoblastic leukaemia

Leukemia

Volumn 10, Issue SUPPL. 2, 1996, Pages

  Bassan, R ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Adult ALL; Anthracyclines; Indications

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; DOXORUBICIN; IDARUBICIN; METHOTREXATE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; GENE TRANSLOCATION; GENETICS; HUMAN; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADOLESCENT; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; DISEASE-FREE SURVIVAL; DOXORUBICIN; HUMANS; IDARUBICIN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; METHOTREXATE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TRANSLOCATION, GENETIC;

EID: 0001765129     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Ames MM, Spreafico F. Selected pharmacologic characteristics of idarubicin and idarubicinol. Leukemia 1992; 6 (Suppl. 1): 70-75.
2. Minderman H, Linssen P, van der Lely N et al. Toxicity of idarubicin and doxorubicin towards normal and leukemic bone marrow progenitors in relation to their proliferative state. Leukemia 1994; 8: 382-387.